To modify chronic inflammation in the context of diabetes, strategies optimising smoking cessation, dietary modification, physical activity, weight loss and the use of statins, GLP1 agonists and SGLT2 inhibitors, may be required [26]. Here, SLC5A2 is linked to diabetes mellitus.